More recently, tau acetylation-mimicking mutations at other prominent sites including K174, K274, K281 induced a series of AD-like deficits including synaptic dysfunction, neuronal loss, and cognitive impairments in viral-transduced and transgenic mouse models, supporting an acetylation-mediated pathological cascade15, 16. This evidence concerns the gene MAPT and Alzheimer disease.